<VariationArchive VariationID="2501779" VariationName="NM_000215.4(JAK3):c.115dup (p.Gln39fs)" VariationType="Duplication" Accession="VCV002501779" Version="2" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-04-06" DateCreated="2023-05-20" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2524718" VariationID="2501779">
      <GeneList>
        <Gene Symbol="JAK3" FullName="Janus kinase 3" GeneID="3718" HGNC_ID="HGNC:6193" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="17824782" stop="17847982" display_start="17824782" display_stop="17847982" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="17935590" stop="17958840" display_start="17935590" display_stop="17958840" Strand="-" />
          </Location>
          <OMIM>600173</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000215.4(JAK3):c.115dup (p.Gln39fs)</Name>
      <CanonicalSPDI>NC_000019.10:17844302:GGGGGGG:GGGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19p13.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="17844302" stop="17844303" display_start="17844302" display_stop="17844303" variantLength="1" positionVCF="17844302" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="17955111" stop="17955112" display_start="17955111" display_stop="17955112" variantLength="1" positionVCF="17955111" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <ProteinChange>Q39fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.17844309dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.17844309dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.17955118dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.17955118dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007273.1" sequenceAccession="NG_007273" sequenceVersion="1" change="g.8689dup">
            <Expression>NG_007273.1:g.8689dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000215.4" sequenceAccession="NM_000215" sequenceVersion="4" change="c.115dup" MANESelect="true">
            <Expression>NM_000215.4:c.115dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000206.2" sequenceAccession="NP_000206" sequenceVersion="2" change="p.Gln39fs">
            <Expression>NP_000206.2:p.Gln39fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000215.3" sequenceAccession="NM_000215" sequenceVersion="3" change="c.115dupC">
            <Expression>NM_000215.3:c.115dupC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_77" sequenceAccession="LRG_77">
            <Expression>LRG_77:g.8689dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_77t1" sequenceAccession="LRG_77t1">
            <Expression>LRG_77t1:c.109dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_77p1" sequenceAccession="LRG_77p1" change="p.Gln39Profs">
            <Expression>LRG_77p1:p.Gln39Profs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000215.3" sequenceAccession="NM_000215" sequenceVersion="3" change="c.115dup">
            <Expression>NM_000215.3:c.115dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000215.4(JAK3):c.115dup (p.Gln39fs) AND T-B+ severe combined immunodeficiency due to JAK3 deficiency" Accession="RCV003228198" Version="2">
        <ClassifiedConditionList TraitSetID="2570">
          <ClassifiedCondition DB="MedGen" ID="C1833275">T-B+ severe combined immunodeficiency due to JAK3 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-04" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000215.4(JAK3):c.115dup (p.Gln39fs) AND Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency" Accession="RCV003340669" Version="2">
        <ClassifiedConditionList TraitSetID="495">
          <ClassifiedCondition DB="MedGen" ID="C1863236">Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-04" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2023-05-20" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11668621</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21184155</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7481768</ID>
        </Citation>
        <DescriptionHistory Dated="2023-10-26">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="495" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3720" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ADA-SCID</ElementValue>
                <XRef Type="MIM" ID="102700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SCID DUE TO ADA DEFICIENCY, EARLY-ONSET</ElementValue>
                <XRef Type="MIM" ID="102700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADA deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adenosine deaminase deficient severe combined immunodeficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Severe combined immunodeficiency due to ADA deficiency</ElementValue>
                <XRef ID="Adenosine+Deaminase+Deficiency/228" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Severe combined immunodeficiency due to adenosine deaminase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency</ElementValue>
                <XRef ID="MONDO:0007064" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Adenosine deaminase (ADA) deficiency is a systemic purine metabolic disorder that primarily affects lymphocyte development, viability, and function. The clinical phenotypic spectrum includes: Severe combined immunodeficiency disease (SCID), often diagnosed by age six months and usually by age 12 months; Less severe "delayed" onset combined immune deficiency (CID), usually diagnosed between age one and ten years; "Late/adult onset" CID, diagnosed in the second to fourth decades; Benign "partial ADA deficiency" (very low or absent ADA activity in erythrocytes but greater ADA activity in nucleated cells), which is compatible with normal immune function. Infants with typical early-onset ADA-deficient SCID have failure to thrive and opportunistic infections associated with marked depletion of T, B, and NK lymphocytes, and an absence of both humoral and cellular immune function. If immune function is not restored, children with ADA-deficient SCID rarely survive beyond age one to two years. Infections in delayed- and late-onset types (commonly, recurrent otitis, sinusitis, and upper respiratory) may initially be less severe than those in individuals with ADA-deficient SCID; however, by the time of diagnosis these individuals often have chronic pulmonary insufficiency and may have autoimmune phenomena (cytopenias, anti-thyroid antibodies), allergies, and elevated serum concentration of IgE. The longer the disorder goes unrecognized, the more immune function deteriorates and the more likely are chronic sequelae of recurrent infection.</Attribute>
                <XRef ID="NBK1483" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5748" />
                <XRef ID="5748" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301656</ID>
                <ID Source="BookShelf">NBK1483</ID>
              </Citation>
              <XRef ID="277" DB="Orphanet" />
              <XRef ID="C1863236" DB="MedGen" />
              <XRef ID="MONDO:0007064" DB="MONDO" />
              <XRef Type="MIM" ID="102700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2570" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4138" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE</ElementValue>
                <XRef Type="MIM" ID="600802" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative</ElementValue>
                <XRef ID="Severe+combined+immunodeficiency%2C+autosomal+recessive%2C+t+cell-negative%2C+b+cell-positive%2C+nk+cell-negative/9287" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">T-B+ severe combined immunodeficiency due to JAK3 deficiency</ElementValue>
                <XRef ID="MONDO:0010938" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SCID, autosomal recessive, T-negative/B-positive type</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Severe Combined Immune Deficiency, Autosomal Recessive, T Cell-Negative, B Cell-Positive, NK Cell-Negative, JAK3-Related</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16632" />
                <XRef ID="16632" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="35078" DB="Orphanet" />
              <XRef ID="C1833275" DB="MedGen" />
              <XRef ID="MONDO:0010938" DB="MONDO" />
              <XRef Type="MIM" ID="600802" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7336316" SubmissionDate="2023-05-08" DateLastUpdated="2023-05-20" DateCreated="2023-05-20">
        <ClinVarSubmissionID localKey="NM_000215.3:c.115dupC|OMIM:600802" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003924285" DateUpdated="2023-05-20" DateCreated="2023-05-20" Type="SCV" Version="1" SubmitterName="Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center" OrgID="508075" OrganizationCategory="other" OrgAbbreviation="CGM_KFSHRC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000215.3:c.115dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600802" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13302310</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7574859" SubmissionDate="2023-10-19" DateLastUpdated="2023-10-28" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="11200111434" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004048123" DateUpdated="2023-10-28" DateCreated="2023-10-28" Type="SCV" Version="1" SubmitterName="Neuberg Centre For Genomic Medicine, NCGM" OrgID="508108" OrganizationCategory="laboratory" OrgAbbreviation="NCGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The frameshift variant c.115dup (p.Gln39ProfsTer13) in JAK3 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Gln39ProfsTer13 variant is novel (not in any individuals) in 1000 Genomes and allele frequency of 0.001282% is reported in gnomAD. This variant causes a frameshift starting with codon Glutamine 39, changes this amino acid to Proline residue, and creates a premature Stop codon at position 13 of the new reading frame, denoted p.Gln39ProfsTer13. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Likely Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002783" />
              </Trait>
              <Comment>A male child was referred for genetic evaluation. Clinical indication- Recurrent chest infections. Death of a sibling due to ?sepsis Clinical suspicion- SCID</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="JAK3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000215.3:c.115dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="102700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13901154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7983604" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4954733|MedGen:C1833275" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004298114" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7481768</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11668621</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21184155</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gln39Profs*13) in the JAK3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in JAK3 are known to be pathogenic (PMID: 7481768, 11668621). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with severe combined immunodeficiency (PMID: 21184155). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as c.115-116insC. ClinVar contains an entry for this variant (Variation ID: 2501779). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="JAK3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.17955111_17955112insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1833275" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7574859" TraitType="Disease" MappingType="XRef" MappingValue="102700" MappingRef="OMIM">
        <MedGen CUI="C1863236" Name="Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7574859" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002783" MappingRef="HP">
        <MedGen CUI="C3163798" Name="Recurrent lower respiratory tract infections" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7983604" TraitType="Disease" MappingType="XRef" MappingValue="C1833275" MappingRef="MedGen">
        <MedGen CUI="C1833275" Name="T-B+ severe combined immunodeficiency due to JAK3 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7336316" TraitType="Disease" MappingType="XRef" MappingValue="600802" MappingRef="OMIM">
        <MedGen CUI="C1833275" Name="T-B+ severe combined immunodeficiency due to JAK3 deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

